Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
RTX may be more effective than CNI in inducing remission in PMN and showed similar efficacy to CTX. CNI may have a high risk of proteinuria relapse and eGFR decline.
Authors
- Xiaoqi Shen
- Luying Lu
- Fei Han (ORCID: https://orcid.org/0000-0001-5363-7556)
- Xiayu Li (ORCID: https://orcid.org/0000-0003-3900-2145)
- Yaomin Wang (ORCID: https://orcid.org/0009-0005-2182-7407)
- Pingping Ren (ORCID: https://orcid.org/0000-0002-4365-9222)
- Jianghua Chen (ORCID: https://orcid.org/0000-0002-3282-3998)
- Lan Lan (ORCID: https://orcid.org/0000-0002-4599-1042)
- Ying Xu (ORCID: https://orcid.org/0000-0003-4170-2271)
- Huayan Zhu
- Shasha Cai (ORCID: https://orcid.org/0000-0002-3297-4702)
- Liangliang Chen
- Guangjun Liu
- Junhao Cheng (ORCID: https://orcid.org/0009-0000-5057-1192)
Institutions
- Third People's Hospital of Huzhou (CN)
- The First People's Hospital of Wenling (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1186/s12882-024-03912-4
- Citations
- 7
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 2.37